In vivo reduction of hepatitis B virus antigenemia and viremia by antisense oligonucleotides. [electronic resource]
- Journal of hepatology Apr 2016
- 781-9 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1600-0641
10.1016/j.jhep.2015.11.032 doi
Animals Hep G2 Cells Hepatitis B Surface Antigens--blood Hepatitis B e Antigens--blood Hepatitis B, Chronic--drug therapy Humans Mice Oligonucleotides, Antisense--therapeutic use Viremia--drug therapy